KYOWA KIRIN CO., LTD.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Public, Subsidiary
- Established
- 1949-07-01
- Employees
- 5.9K
- Market Cap
- -
- Website
- http://www.kyowa-kirin.co.jp
A Study of KW-0761 in Subjects With HTLV-1 Associated Myelopathy (HAM)
Phase 3
Terminated
- Conditions
- HTLV-1 Associated Myelopathy
- Interventions
- Drug: KW-0761 0.3 mg/kg IVDrug: Placebo (saline)
- First Posted Date
- 2017-06-19
- Last Posted Date
- 2022-04-14
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 66
- Registration Number
- NCT03191526
- Locations
- 🇯🇵
Kansai Medical University Hosipital, Hirakata, Osaka Prefecture, Japan
🇯🇵University Hosipital, Kyoto Prefectural University of Medicine, Kyoto, Japan
🇯🇵University of the Ryukyus Hospital, Nakagami, Okinawa Prefecture, Japan
A Phase 1 Study of KHK4083 in Subjects With Atopic Dermatitis
- First Posted Date
- 2017-03-30
- Last Posted Date
- 2018-03-27
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 26
- Registration Number
- NCT03096223
- Locations
- 🇯🇵
Closed information, Sapporo, Japan
A Repeated Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease
- First Posted Date
- 2017-03-28
- Last Posted Date
- 2018-03-20
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 21
- Registration Number
- NCT03093519
- Locations
- 🇯🇵
Closed information, Saitama, Japan
A Phase 1 Study of KHK4083 in Healthy Volunteers and Subjects With Ulcerative Colitis
Phase 1
Completed
- Conditions
- Healthy Men and Subjects With Ulcerative Colitis
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-12-07
- Last Posted Date
- 2023-08-30
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 155
- Registration Number
- NCT02985593
A Study of Brodalumab in Subjects With Axial Spondyloarthritis (axSpA)
- First Posted Date
- 2016-12-07
- Last Posted Date
- 2024-07-16
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 159
- Registration Number
- NCT02985983
- Locations
- 🇯🇵
Tenri Hospital, Nara, Japan
🇯🇵Fukuoka University Hospital, Fukuoka, Japan
🇯🇵Kyusyu University Hospital, Fukuoka, Japan
A Study of KW-6356 in Subjects With Early Parkinson's Disease
- First Posted Date
- 2016-10-20
- Last Posted Date
- 2018-03-20
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 175
- Registration Number
- NCT02939391
Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia
Phase 2
Completed
- Conditions
- Aplastic Anemia
- Interventions
- Biological: Romiplostim
- First Posted Date
- 2016-05-16
- Last Posted Date
- 2024-07-16
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 46
- Registration Number
- NCT02773290
Study of Benralizumab (KHK4563) in Patients With Eosinophilic Chronic Rhinosinusitis
Phase 2
Completed
- Conditions
- Eosinophilic Chronic Rhinosinusitis
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-05-13
- Last Posted Date
- 2018-04-23
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 63
- Registration Number
- NCT02772419
A Study of KRN23 in Subjects With Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome
Phase 2
Completed
- Conditions
- Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome
- Interventions
- First Posted Date
- 2016-03-30
- Last Posted Date
- 2022-09-06
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 14
- Registration Number
- NCT02722798
Study of KHK2375 in Subjects With Advanced or Recurrent Breast Cancer
- First Posted Date
- 2015-12-08
- Last Posted Date
- 2022-06-21
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 15
- Registration Number
- NCT02623751
© Copyright 2025. All Rights Reserved by MedPath